Sage Journals: Discover world-class research

Retricted access

Research article

First published 2017-12

Transparency at the U.S. Food and Drug Administration

Robert M. Califf

The Journal of Law,Medicine & Ethics

Retricted access

Research article

First published 2009-02

The U.S. Food and Drug Administration's Evaluation of the Safety of Animal Clones

Zahra Meghani, Inmaculada de Melo-Martín

Bulletin of Science,Technology & Society

Retricted access

Research article

First published 2021-12

The U.S. Food and Drug Administration’s Complex Innovative Trial Design Pilot Meeting Program: Progress to date

Dionne Price, John Scott

Clinical Trials

Retricted access

Research article

First published 2026

Premarket and postmarket real-world evidence studies supporting U.S. Food and Drug Administration regulatory decision-making,2016–2024

Louis Y Li, Reshma Ramachandran, Joseph S Ross [...]

Clinical Trials

Retricted access

Research article

First published 2020-4

Estimated costs of pivotal trials for U.S. Food and Drug Administration–approved cancer drugs,2015–2017

Emily Han-Chung Hsiue, Thomas J Moore, G Caleb Alexander

Clinical Trials

Retricted access

Article commentary

First published 2023-7

The U.S. Food and Drug Administration,the mechanism of action,and other considerations for cell-based therapy candidates

Arnold I Caplan

Experimental Biology and Medicine

Retricted access

Research article

First published 2017-12

Blueprint for Transparency at the U.S. Food and Drug Administration: Recommendations to Advance the Development of Safe and Effective Medical Products

Joshua M. Sharfstein, James Dabney Miller, Anna L. Davis [...]

The Journal of Law,Medicine & Ethics

Retricted access

Research article

First published 2012-9

Agenda-Building Influences on the News Media's Coverage of the U.S. Food and Drug Administration's Push to Regulate Tobacco,1993–2009

Caroline Foster, Jim Thrasher, Sei-Hill Kim [...]

Journal of Health and Human Services Administration

Retricted access

News

First published 2012-03

A False Sense of Security? The U.S. Food and Drug Administration's Framework for Evaluating New Supplement Ingredients

Pieter A. Cohen

Antioxidants & Redox Signaling

Free access

Research article

First published 2014-6

Trends in Bone Morphogenetic Protein Usage since the U.S. Food and Drug Administration Advisory in 2008: What Happens to Physician Practices When the Food and Drug Administration Issues an Advisory?

Janay Mckie, Sheeraz Qureshi, James Iatridis [...]

Global Spine Journal

Search results